Nature Communications (Aug 2022)

Blocking ActRIIB and restoring appetite reverses cachexia and improves survival in mice with lung cancer

  • Andre Lima Queiroz,
  • Ezequiel Dantas,
  • Shakti Ramsamooj,
  • Anirudh Murthy,
  • Mujmmail Ahmed,
  • Elizabeth R. M. Zunica,
  • Roger J. Liang,
  • Jessica Murphy,
  • Corey D. Holman,
  • Curtis J. Bare,
  • Gregory Ghahramani,
  • Zhidan Wu,
  • David E. Cohen,
  • John P. Kirwan,
  • Lewis C. Cantley,
  • Christopher L. Axelrod,
  • Marcus D. Goncalves

DOI
https://doi.org/10.1038/s41467-022-32135-0
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 17

Abstract

Read online

Cancer-associated cachexia is characterized by loss of body weight, skeletal muscle and adipose tissue which relates to higher mortality in cancer patients. Here, the authors show in a lung cancer murine model that both ActRIIB signalling inhibition and restoring appetite are necessary to revert cachexia and improve survival in female mice.